The developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia (B-ALL) was identified by comparison of bulk and single-cell leukemia transcriptomes with those of a human fetal bone marrow reference. Unlike standard-risk childhood B-ALL, this aggressive leukemia was characterized by early lymphocyte precursor (ELP) differentiation. Moreover, in contrast to healthy ELPs, KMT2A-rearranged infant B-ALL cells had both myeloid and lymphoid features and expressed potentially targetable novel combinations of antigens.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jardine, L. & Webb, S. et al. Blood and immune development in human fetal bone marrow and Down syndrome. Nature 7880, 327–331 (2021). This paper reports a single-cell atlas of developing bone marrow.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Khabirova, E. et al. Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia. Nat. Med. https://doi.org/10.1038/s41591-022-01720-7 (2022).
Rights and permissions
About this article
Cite this article
A distinct hematopoietic differentiation state characterizes aggressive infant leukemia. Nat Med 28, 641–642 (2022). https://doi.org/10.1038/s41591-022-01719-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-01719-0
